107.44 USD
+0.10
0.09%
At close Apr 17, 4:00 PM EDT
After hours
107.44
+0.00
0.00%
1 day
0.09%
5 days
2.64%
1 month
-0.89%
3 months
0.89%
6 months
-6.57%
Year to date
4.96%
1 year
33.86%
5 years
194.52%
10 years
235.85%
 

About: Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Employees: 12,694

0
Funds holding %
of 7,407 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

50% more call options, than puts

Call options by funds: $427M | Put options by funds: $284M

45% more first-time investments, than exits

New positions opened: 161 | Existing positions closed: 111

1% more funds holding

Funds holding: 1,524 [Q3] → 1,539 (+15) [Q4]

0.21% more ownership

Funds ownership: 66.54% [Q3] → 66.76% (+0.21%) [Q4]

4% less capital invested

Capital invested by funds: $41.6B [Q3] → $40.1B (-$1.49B) [Q4]

13% less repeat investments, than reductions

Existing positions increased: 496 | Existing positions reduced: 571

23% less funds holding in top 10

Funds holding in top 10: 30 [Q3] → 23 (-7) [Q4]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$95
12%
downside
Avg. target
$106
2%
downside
High target
$124
15%
upside

8 analyst ratings

positive
13%
neutral
75%
negative
13%
Morgan Stanley
Nigel Dally
45% 1-year accuracy
5 / 11 met price target
7%downside
$100
Equal-Weight
Maintained
10 Apr 2025
UBS
Brian Meredith
81% 1-year accuracy
26 / 32 met price target
6%upside
$114
Neutral
Maintained
2 Apr 2025
Piper Sandler
John Barnidge
40% 1-year accuracy
19 / 48 met price target
15%upside
$124
Overweight
Maintained
2 Apr 2025
JP Morgan
Jimmy Bhullar
61% 1-year accuracy
22 / 36 met price target
11%downside
$96
Neutral
Maintained
2 Apr 2025
Wells Fargo
Elyse Greenspan
59% 1-year accuracy
68 / 116 met price target
5%downside
$102
Equal-Weight
Maintained
19 Feb 2025

Financial journalist opinion

Based on 3 articles about AFL published over the past 30 days

Positive
Zacks Investment Research
2 weeks ago
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Neutral
PRNewsWire
2 weeks ago
Aflac Incorporated to Release First Quarter Results and CFO Video Update on April 30, 2025 and Host Webcast on May 1, 2025
COLUMBUS, Ga. , April 3, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release first quarter 2025 financial results after the market closes on April 30, 2025.
Aflac Incorporated to Release First Quarter Results and CFO Video Update on April 30, 2025 and Host Webcast on May 1, 2025
Positive
The Motley Fool
3 weeks ago
Want Decades of Passive Income? 3 Reliable Dividend Stocks to Buy Right Now
Investing in the stock market is a great way to build long-term, sustainable wealth. Dividend-paying stocks can be solid investments because these companies exhibit strong business models.
Want Decades of Passive Income? 3 Reliable Dividend Stocks to Buy Right Now
Positive
Zacks Investment Research
1 month ago
5 Stocks to Watch From Prospering Accident & Health Insurance Industry
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM, TRUP, EIG and AMSF.
5 Stocks to Watch From Prospering Accident & Health Insurance Industry
Positive
Seeking Alpha
1 month ago
Dividend Kings Of The Future Continued
A list of 8 companies that are projected to reach Dividend King status in the future. These companies offer various dividend yields ranging from 0.80% to nearly 4.5%. The average 10-year dividend growth rate for these 8 companies is 8.6%, well above typical inflation.
Dividend Kings Of The Future Continued
Neutral
PRNewsWire
1 month ago
TOGETHXR and Aflac Put More Ducks in a Row for Women's Sports
Continued partnership launches Raise the Bar campaign for equal basketball tournament tune-ins from March 17-April 6 TOGETHXR.com  published a digital map featuring bars where everyone can watch women's sports LOS ANGELES and COLUMBUS, Ga. , March 18, 2025 /PRNewswire/ -- As the originator of the Everyone Watches Women's Sports™ mantra, trailblazing media and commerce company TOGETHXR is once again teaming up with Aflac – the leading provider of supplemental health insurance in the U.S.1 – to increase women's sports viewership during the height of the women's college basketball season.
TOGETHXR and Aflac Put More Ducks in a Row for Women's Sports
Neutral
PRNewsWire
1 month ago
Aflac is a World's Most Ethical Company for 19th year in a row
Only insurance company in the world to be on this list since its inception in 2007 COLUMBUS, Ga. , March 11, 2025 /PRNewswire/ -- Aflac Incorporated, a leading provider of health supplemental insurance in the U.S. and the leading provider of cancer and medical insurance in terms of policies in force in Japan, was once again named by Ethisphere as one of the World's Most Ethical Companies, marking 2025 as the 19th consecutive year on this esteemed list.
Aflac is a World's Most Ethical Company for 19th year in a row
Neutral
Seeking Alpha
1 month ago
The Dividend Aristocrats Ranked By Quality Scores: March 2025
S&P Dow Jones Indices added three new members to the S&P 500 Dividend Aristocrats Index, expanding it to 69 companies. I rank Dividend Aristocrats by quality scores, presenting undervalued and overvalued stocks with detailed metrics and fair value estimates. My quality scoring system uses six indicators, each worth 5 points, for a maximum score of 30, categorizing stocks from Exceptional to Inferior.
The Dividend Aristocrats Ranked By Quality Scores: March 2025
Positive
Seeking Alpha
1 month ago
2 Attractively Priced, High Yield Stocks For Income Durability As The Market Hits New Highs
Hyperinflation and high interest rates make dividend-paying stocks attractive, providing cash flow and alleviating inflation pressure. Pfizer's 6% yield is appealing despite recent stock declines, with a low forward multiple and management's commitment to maintaining dividends. Cost savings and Haleon share sales should support Pfizer's dividend yield, with free cash flow expected to improve next year.
2 Attractively Priced, High Yield Stocks For Income Durability As The Market Hits New Highs
Positive
Seeking Alpha
1 month ago
My Best Dividend Aristocrats For March 2025
The ProShares S&P 500 Dividend Aristocrat ETF kicks off 2025 on a bright note with a gain of 2.81% in January. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 43 months of tracking these strategies, one strategy is generating a CAGR superior to NOBL.
My Best Dividend Aristocrats For March 2025
Charts implemented using Lightweight Charts™